Chronic kidney disease caused by maternally inherited diabetes and deafness: a case report.


Journal

CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244

Informations de publication

Date de publication:
05 2021
Historique:
received: 25 07 2020
accepted: 15 10 2020
pubmed: 31 10 2020
medline: 25 11 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

Maternally inherited diabetes and deafness (MIDD) is a mitochondrial genetic disorder with variable clinical presentations, which can delay its diagnosis. Herein, we report the case of a 57-year-old Japanese man with MIDD who developed chronic kidney disease. He developed proteinuria long before his diabetes and deafness; at the age of 36 years, a renal biopsy showed minor glomerular abnormality and electron microscopy showed mild mitochondrial degeneration in the distal tubular epithelial cells. Twenty years later, a second renal biopsy showed nephrosclerosis with interstitial fibrosis and arteriolar hyaline thickening, despite the absence of hypertension and relatively good glycemic control. Granular swollen epithelial cells were found in the medullary collecting duct epithelium. Electron microscopy showed accumulating mitochondria in podocytes and tubular cells, leading to the diagnosis of MIDD. A muscle biopsy also showed ragged-red fibers, despite the absence of muscle weakness. Mitochondrial DNA analysis revealed an m.3243A > G mutation, and taurine supplementation was initiated. Our findings suggest that mitochondrial dysfunction is mainly associated with progressive renal damage.

Identifiants

pubmed: 33125665
doi: 10.1007/s13730-020-00547-w
pii: 10.1007/s13730-020-00547-w
pmc: PMC8019445
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-225

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

BMC Genomics. 2009 Aug 21;10:388
pubmed: 19698090
Diabetes Res Clin Pract. 2003 Mar;59(3):207-17
pubmed: 12590018
Circ Res. 2007 Mar 2;100(4):460-73
pubmed: 17332437
Front Endocrinol (Lausanne). 2014 Dec 15;5:209
pubmed: 25566185
EMBO J. 2001 Sep 3;20(17):4794-802
pubmed: 11532943
Clin Nephrol. 2013 Dec;80(6):456-63
pubmed: 22909780
Am J Surg Pathol. 2010 Feb;34(2):262-70
pubmed: 20090504
Nephrol Dial Transplant. 2000 Mar;15(3):385-8
pubmed: 10692525
Am J Physiol Renal Physiol. 2014 Feb 15;306(4):F367-78
pubmed: 24305473
Int J Biochem Cell Biol. 2013 Sep;45(9):2109-18
pubmed: 23806869
Ann Med. 2005;37(3):213-21
pubmed: 16019720
Nat Rev Nephrol. 2016 May;12(5):267-80
pubmed: 26804019
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Ann Intern Med. 2001 May 1;134(9 Pt 1):721-8
pubmed: 11329229
Diabetologia. 1998 May;41(5):584-8
pubmed: 9628277
J Am Soc Nephrol. 2003 Aug;14(8):2099-108
pubmed: 12874464
J Biol Chem. 2000 Feb 11;275(6):4251-7
pubmed: 10660592
Kidney Int. 2001 Apr;59(4):1236-43
pubmed: 11260383
J Neurol Neurosurg Psychiatry. 2019 May;90(5):529-536
pubmed: 29666206

Auteurs

Kenta Tanaka (K)

Department of Nephrology, Hiroshima Prefectural Hospital, 1-5-54, Ujinakanda, Minami-ku, Hiroshima, 734-8530, Japan.

Toshinori Ueno (T)

Department of Nephrology, Hiroshima Prefectural Hospital, 1-5-54, Ujinakanda, Minami-ku, Hiroshima, 734-8530, Japan. tueno-ygc@umin.ac.jp.

Maria Yoshida (M)

Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan.

Yuka Shimizu (Y)

Department of Nephrology, Hiroshima Prefectural Hospital, 1-5-54, Ujinakanda, Minami-ku, Hiroshima, 734-8530, Japan.

Takahiko Ogawa (T)

Department of Nephrology, Hiroshima Prefectural Hospital, 1-5-54, Ujinakanda, Minami-ku, Hiroshima, 734-8530, Japan.

Takashi Nishisaka (T)

Department of Pathology, Hiroshima Prefectural Hospital, Hiroshima, Japan.

Takashi Kurashige (T)

Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.

Takao Masaki (T)

Department of Nephrology, Hiroshima University Hospital, Hiroshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH